Last reviewed · How we verify

TECHNETIUM TC 99M OXIDRONATE

FDA-approved approved Small molecule Quality 2/100

TECHNETIUM TC 99M OXIDRONATE is a drug. It is currently FDA-approved (first approved 1982).

At a glance

Generic nameTECHNETIUM TC 99M OXIDRONATE
ModalitySmall molecule
PhaseFDA-approved
First approval1982

Approved indications

No approved indications tracked.

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about TECHNETIUM TC 99M OXIDRONATE

What is TECHNETIUM TC 99M OXIDRONATE?

TECHNETIUM TC 99M OXIDRONATE is a Small molecule drug.

When was TECHNETIUM TC 99M OXIDRONATE approved?

TECHNETIUM TC 99M OXIDRONATE was first approved on 1982.

What development phase is TECHNETIUM TC 99M OXIDRONATE in?

TECHNETIUM TC 99M OXIDRONATE is FDA-approved (marketed).

What are the side effects of TECHNETIUM TC 99M OXIDRONATE?

Common side effects of TECHNETIUM TC 99M OXIDRONATE include Nausea, Vomiting, Injection site reactions. Serious adverse events: Hypersensitivity reactions, Life-threatening reactions.

Related